2010
Soucek, Karel; Gajdusková, Pavla; Brázdová, Marie; Hýzd'alová, Martina; Kocí, Lenka; Vydra, David; Trojanec, Radek; Pernicová, Zuzana; Lentvorská, Lenka; Hajdúch, Marián; Hofmanová, Jirina; Kozubík, Alois
Fetal colon cell line FHC exhibits tumorigenic phenotype, complex karyotype, and TP53 gene mutation. Journal Article
In: Cancer genetics and cytogenetics, vol. 197, no. 2, pp. 107–116, 2010, ISSN: 1873-4456 0165-4608, (Place: United States).
Abstract | Links | BibTeX | Tags: *Genes, Animals, Apoptosis/physiology, Carcinoembryonic Antigen/metabolism, Cell Adhesion/physiology, Cell Growth Processes/physiology, Cell Line, Cell Transformation, Colon/cytology/metabolism/*physiology, Colonic Neoplasms/*genetics/*pathology, Comparative Genomic Hybridization, Cytogenetic Analysis/methods, DNA Damage, DNA Mutational Analysis/methods, Female, Fetus/cytology, Fluorescence, HCT116 Cells, Humans, In Situ Hybridization, Karyotyping, Keratins/metabolism, Mice, Neoplasm Transplantation, Neoplastic/genetics/pathology, p53, Phenotype, Proto-Oncogene Mas, SCID, Signal Transduction, Transformed
@article{soucek_fetal_2010,
title = {Fetal colon cell line FHC exhibits tumorigenic phenotype, complex karyotype, and TP53 gene mutation.},
author = {Karel Soucek and Pavla Gajdusková and Marie Brázdová and Martina Hýzd'alová and Lenka Kocí and David Vydra and Radek Trojanec and Zuzana Pernicová and Lenka Lentvorská and Marián Hajdúch and Jirina Hofmanová and Alois Kozubík},
doi = {10.1016/j.cancergencyto.2009.11.009},
issn = {1873-4456 0165-4608},
year = {2010},
date = {2010-03-01},
journal = {Cancer genetics and cytogenetics},
volume = {197},
number = {2},
pages = {107–116},
abstract = {Stable cell lines obtained by spontaneous immortalization might represent early stages of malignant transformation and be useful experimental models for studies of mechanisms of cancer development. The FHC (fetal human cells) cell line has been established from normal fetal colonic mucosa. Detailed characterization of this cell line and mechanism of spontaneously acquired immortality have not been described yet. Therefore, we characterized the FHC cell line in terms of its tumorigenicity, cytogenetics, and TP53 gene mutation analysis. FHC cells displayed capability for anchorage-independent growth in semisolid media in vitro and formed solid tumors after transplantation into SCID (severe combined immunodeficiency) mice. This tumorigenic phenotype was associated with hypotriploidy and chromosome number ranging from 66 to 69. Results of comparative genetic hybridization arrays showed that most chromosomes included regions of copy number gains or losses. Region 8q23 approximately 8q24.3 (containing, e.g., MYC proto-oncogene) was present in more than 20 copies per nucleus. Moreover, we identified mutation of TP53 gene in codon 273; triplet CGT coding Arg was changed to CAG coding His. Expression of Pro codon 72 polymorphic variant of p53 was also detected. Mutation of TP53 gene was associated with abolished induction of p21(Waf1/Cip1) and MDM-2 proteins and resistance to apoptosis after genotoxic treatment. Because of their origin from normal fetal colon and their relative resistance to the induction of apoptosis, FHC cells can be considered a valuable experimental model for various studies.},
note = {Place: United States},
keywords = {*Genes, Animals, Apoptosis/physiology, Carcinoembryonic Antigen/metabolism, Cell Adhesion/physiology, Cell Growth Processes/physiology, Cell Line, Cell Transformation, Colon/cytology/metabolism/*physiology, Colonic Neoplasms/*genetics/*pathology, Comparative Genomic Hybridization, Cytogenetic Analysis/methods, DNA Damage, DNA Mutational Analysis/methods, Female, Fetus/cytology, Fluorescence, HCT116 Cells, Humans, In Situ Hybridization, Karyotyping, Keratins/metabolism, Mice, Neoplasm Transplantation, Neoplastic/genetics/pathology, p53, Phenotype, Proto-Oncogene Mas, SCID, Signal Transduction, Transformed},
pubstate = {published},
tppubtype = {article}
}
2008
Ondrousková, Eva; Soucek, Karel; Horváth, Viktor; Smarda, Jan
Alternative pathways of programmed cell death are activated in cells with defective caspase-dependent apoptosis. Journal Article
In: Leukemia research, vol. 32, no. 4, pp. 599–609, 2008, ISSN: 0145-2126, (Place: England).
Abstract | Links | BibTeX | Tags: Animals, Antineoplastic Agents/*pharmacology, Apoptosis/*drug effects, Arsenic Trioxide, Arsenicals/pharmacology, Autophagy/*drug effects, Blotting, Camptothecin/pharmacology, Caspases/*metabolism, Cell Line, Cell Transformation, Chickens, Cycloheximide/pharmacology, Fluorescence, Genes, Humans, Microscopy, myb/physiology, Necrosis, Neoplastic/*pathology, Oxides/pharmacology, Signal Transduction/*drug effects, Transformed, U937 Cells/drug effects, Western
@article{ondrouskova_alternative_2008,
title = {Alternative pathways of programmed cell death are activated in cells with defective caspase-dependent apoptosis.},
author = {Eva Ondrousková and Karel Soucek and Viktor Horváth and Jan Smarda},
doi = {10.1016/j.leukres.2007.05.012},
issn = {0145-2126},
year = {2008},
date = {2008-04-01},
journal = {Leukemia research},
volume = {32},
number = {4},
pages = {599–609},
abstract = {Loss of programmed cell death pathways is one of the features of malignancy that complicate the response of cancer cells to a therapy. Activation of alternative cell death pathways offers a promising approach to enhance efficiency of cancer chemotherapy. We analysed programmed cell death pathways of v-myb-transformed BM2 monoblasts induced by arsenic trioxide, cycloheximide and camptothecin with U937 promonocytes as a reference cell line. We show that induced death of BM2 cells is not executed by caspases but rather by alternative cell death pathways. Camptothecin induces the lysosome-dependent cell death, arsenic trioxide induces autophagy, and most of cycloheximide-treated BM2 cells die by necrosis. The fact that alternative cell death pathways can be switched in cells with defects in activation and/or function of caspases suggests that understanding and targeting of these pathways could improve therapy of cancer cells suffering from defective apoptosis.},
note = {Place: England},
keywords = {Animals, Antineoplastic Agents/*pharmacology, Apoptosis/*drug effects, Arsenic Trioxide, Arsenicals/pharmacology, Autophagy/*drug effects, Blotting, Camptothecin/pharmacology, Caspases/*metabolism, Cell Line, Cell Transformation, Chickens, Cycloheximide/pharmacology, Fluorescence, Genes, Humans, Microscopy, myb/physiology, Necrosis, Neoplastic/*pathology, Oxides/pharmacology, Signal Transduction/*drug effects, Transformed, U937 Cells/drug effects, Western},
pubstate = {published},
tppubtype = {article}
}
2003
Nemajerová, Alice; Smarda, Jan; Jurdic, Pierre; Kubala, Lukás; Soucek, Karel; Smardová, Jana
Trichostatin A suppresses transformation by the v-myb oncogene in BM2 cells. Journal Article
In: Journal of hematotherapy & stem cell research, vol. 12, no. 2, pp. 225–235, 2003, ISSN: 1525-8165, (Place: United States).
Abstract | Links | BibTeX | Tags: Acetylation, Animals, Cell Cycle, Cell Differentiation, Cell Line, Cell Transformation, Chickens, Chromatin Assembly and Disassembly/physiology, Genes, Histone Deacetylases/drug effects, Histones/metabolism/physiology, Hydroxamic Acids/*pharmacology, Macrophages/cytology, myb/drug effects/*physiology, Transformed, Viral/*drug effects
@article{nemajerova_trichostatin_2003,
title = {Trichostatin A suppresses transformation by the v-myb oncogene in BM2 cells.},
author = {Alice Nemajerová and Jan Smarda and Pierre Jurdic and Lukás Kubala and Karel Soucek and Jana Smardová},
doi = {10.1089/152581603321628368},
issn = {1525-8165},
year = {2003},
date = {2003-04-01},
journal = {Journal of hematotherapy & stem cell research},
volume = {12},
number = {2},
pages = {225–235},
abstract = {BM2 cells are chicken monoblasts transformed by the v-myb oncogene of avian myeloblastosis virus. The constitutively high v-myb expression interferes with the terminal differentiation of BM2 cells, but these cells can be induced to differentiate into macrophage-like cells by phorbol esters. Histone acetylation plays an important role in regulation of transcription and is particularly relevant to the regulation and pathology of hematopoiesis. In the present study, we examined the contribution of elevated histone acetylation to the differentiation of BM2 cells. Inhibition of the activity of endogenous histone deacetylases by trichostatin A (TSA) resulted in histone hyperacetylation causing cell cycle arrest and differentiation of BM2 cells into macrophage polykaryons. TSA did not affect the level of v-Myb protein in BM2 cells, but it downregulated its transcription activation capability. This suggests that chromatin remodeling can be significantly engaged in regulation of proliferation and differentiation of leukemic cells.},
note = {Place: United States},
keywords = {Acetylation, Animals, Cell Cycle, Cell Differentiation, Cell Line, Cell Transformation, Chickens, Chromatin Assembly and Disassembly/physiology, Genes, Histone Deacetylases/drug effects, Histones/metabolism/physiology, Hydroxamic Acids/*pharmacology, Macrophages/cytology, myb/drug effects/*physiology, Transformed, Viral/*drug effects},
pubstate = {published},
tppubtype = {article}
}
2002
Pacherník, Jirí; Hampl, Ales; Soucek, Karel; Kovaríková, Martina; Andrysík, Zdenek; Hofmanová, Jirina; Kozubík, Alois
Multiple biological effects of inhibitors of arachidonic acid metabolism on human keratinocytes. Journal Article
In: Archives of dermatological research, vol. 293, no. 12, pp. 626–633, 2002, ISSN: 0340-3696, (Place: Germany).
Abstract | Links | BibTeX | Tags: 11, 14-Eicosatetraynoic Acid/pharmacology, 5, 8, Arachidonic Acid/*antagonists & inhibitors, Cell Differentiation/drug effects, Cell Division/drug effects, Cell Line, Cell Survival/drug effects, Cyclooxygenase Inhibitors/pharmacology, Humans, Indoles/pharmacology, Keratinocytes/cytology/*drug effects/*physiology, Lipoxygenase Inhibitors/pharmacology, Transformed, Umbelliferones/pharmacology
@article{pachernik_multiple_2002,
title = {Multiple biological effects of inhibitors of arachidonic acid metabolism on human keratinocytes.},
author = {Jirí Pacherník and Ales Hampl and Karel Soucek and Martina Kovaríková and Zdenek Andrysík and Jirina Hofmanová and Alois Kozubík},
doi = {10.1007/s00403-001-0288-5},
issn = {0340-3696},
year = {2002},
date = {2002-02-01},
journal = {Archives of dermatological research},
volume = {293},
number = {12},
pages = {626–633},
abstract = {BACKGROUND: Various compounds that inhibit processing of arachidonic acid (AA) are being intensively tested for their antitumour activity. However, the mechanisms responsible for such activity remain rather elusive. To approach this issue, we examined the effects of several structurally different inhibitors of AA metabolism in the human keratinocyte HaCaT cell line. METHODS: Several parameters were determined in HaCaT cells exposed to increasing concentrations of the inhibitors for 24 and/or 48 h. These included (1) oxidoreductase activity, total protein mass and cell cycle distribution to assess cell proliferation, (2) degradation of PARP protein to assess apoptosis, and (3) cell morphology, distribution of F-actin and expression of cytokeratins and E-cadherin to evaluate changes in differentiation status. RESULTS: While eicosatetraynoic acid (ETYA), nordihydroguaiaretic acid (NDGA), esculetin and MK-886 reduced proliferation of HaCaT cells, the cyclooxygenase inhibitors indomethacin and piroxicam had no such effects. Esculetin and NDGA arrested cells in S phase, and ETYA and MK-886 delayed cell progression through G(1) phase. Higher concentrations of NDGA, MK886 and/or ETYA caused cleavage of PARP. No changes in the expression of cytokeratins and E-cadherin were observed upon treatment with any of the inhibitors. However, esculetin induced redistribution of F-actin accompanied by increased cell adhesion and size. CONCLUSION: Our findings indicate that, in addition to their ability to inhibit cell proliferation and to induce apoptosis, lipoxygenase inhibitors and/or ETYA may also elicit other important physiological responses in HaCaT keratinocytes.},
note = {Place: Germany},
keywords = {11, 14-Eicosatetraynoic Acid/pharmacology, 5, 8, Arachidonic Acid/*antagonists & inhibitors, Cell Differentiation/drug effects, Cell Division/drug effects, Cell Line, Cell Survival/drug effects, Cyclooxygenase Inhibitors/pharmacology, Humans, Indoles/pharmacology, Keratinocytes/cytology/*drug effects/*physiology, Lipoxygenase Inhibitors/pharmacology, Transformed, Umbelliferones/pharmacology},
pubstate = {published},
tppubtype = {article}
}